|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
A method to determine stroke trial success using multidimensional pooled control functions.
|
19286598 |
2009 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
|
29171359 |
2018 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.
|
8427107 |
1993 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke.
|
14657446 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
[Thrombolysis in acute ischemic stroke in basic hospitals. four cases reports].
|
20488584 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
|
9259745 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation.
|
20705933 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial.
|
11239184 |
2001 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Dosing errors may impact the risk of rt-PA for stroke: the Multicenter rt-PA Acute Stroke Survey.
|
17903947 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Thrombolysis in patients with transient neurologic deficits.
|
11739841 |
2001 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study.
|
11113218 |
2000 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Nursing management of acute complications following rt-PA in acute ischemic stroke. The NINDS rt-PA Stroke Study Group.
|
9479658 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
BEFREE |
Symptoms of acute stroke and MS can overlap and the lack of clear clinical/radiological criteria that alert the patient or clinician to the development of acute stroke in an MS patient compound the dilemma, even leading to the administration of IV alteplase in cases that are later diagnosed as either MS or having an "MS flare."
|
30135678 |
2018 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
The Interventional Management of Stroke (IMS) II Study.
|
17525387 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
|
14986460 |
2004 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Predicting outcome in ischemic stroke: external validation of predictive risk models.
|
12511774 |
2003 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.
|
9479657 |
1997 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Lack of association between hyperglycaemia at arrival and clinical outcomes in acute stroke patients treated with tissue plasminogen activator.
|
20536612 |
2010 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
Thrombolysis, stroke units and other strategies for reducing acute stroke costs.
|
10346413 |
1998 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Therapeutic
|
disease |
CTD_human |
NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
|
18369171 |
2008 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors.
|
9836764 |
1998 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Intravenous thrombolysis for acute ischemic stroke: the phase IV data.
|
17903870 |
2007 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Thrombolysis for acute stroke in routine clinical practice.
|
12230423 |
2002 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
|
11940547 |
2002 |
|
Acute Cerebrovascular Accidents
|
0.360 |
Biomarker
|
disease |
CTD_human |
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.
|
9566367 |
1998 |